ライフサイエンスコーパス: immunoglobulin E

1 rmalized circulating levels of cytokines and immunoglobulin E.

2 mpaired in mastocytosis or allergen-specific immunoglobulin E.

3 r "aptamer" designed to bind specifically to immunoglobulin E.

4 d by T helper type 2 cytokines and increased immunoglobulin E.

5 high levels of interleukin (IL)-5, IL-4, and immunoglobulin E.

6 n 5 in the lung, and reduced serum levels of immunoglobulin E.

7 s to common allergens, which are mediated by immunoglobulin E.

8 rface expression by a 4-d preincubation with immunoglobulin E.

9 lycerides,.37; diastolic blood pressure,.21; immunoglobulin E,.63; lipoprotein(a),.77; and body-mass

10 Serum immunoglobulin E against eight common inhalant and six f

11 sensitization by specific serum antibodies (immunoglobulin E) against aero-allergens.

12 aggregation of Fc epsilon RI receptors with immunoglobulin E and antigen is mediated through the act

13 Specific immunoglobulin E and bronchial hyper-responsiveness were

14 asthma phenotypes, such as high total serum immunoglobulin E and bronchial hyperresponsiveness, have

15 of asthma in a manner that is independent of immunoglobulin E and eosinophils.

16 Total serum immunoglobulin E and FEV1 predicted levels were not asso

17 We measured specific immunoglobulin E and G4 directed to recombinant A. fumig

18 -alpha-treated mice exhibited elevated serum immunoglobulin E and inhibition of the anticryptococcal

19 Immunoglobulin E and its interactions with receptors FcR

20 oded nanopores to detect single molecules of immunoglobulin E and the bioterrorist agent ricin, seque

21 h2 response was accompanied by production of immunoglobulin E and the sensitization of circulating ba

22 eutic approaches, including the targeting of immunoglobulin E and tumour necrosis factor alpha with b

23 a mutant deficient in delta-toxin, promoted immunoglobulin-E and interleukin-4 production, as well a

24 amers against a surface-immobilized protein (immunoglobulin E) and a solution-phase small molecule (b

25 with asthma, AHR, lung function, total serum immunoglobulin E, and blood eosinophil levels.

26 Th2 cell skewing was dependent on basophils, immunoglobulin E, and interleukin-4, but was independent

27 terleukin-5 (IL-5), IL-13, gamma interferon, immunoglobulin E, and mucus-secreting cells.

28 Aptamers for human alpha-thrombin, immunoglobulin E, and platelet-derived growth factor B w

29 e function and development, such as allergy, immunoglobulin E, and Varicella infection status.

30 Anti-immunoglobulin E (anti-IgE) (omalizumab), a humanized mo

31 at year 1 and repeated assessments of serum immunoglobulin E antibodies (year 1, 4.5, 6), atopic der

32 xpectedly, FcgammaRIV 'preferentially' bound immunoglobulin E antibodies of the 'b' allotype (IgE(b))

33 allergens in home dust samples, and specific immunoglobulin E antibodies were measured at outset, and

34 ex sensitization (measured by latex-specific immunoglobulin E antibodies) by using data from 5,512 ad

35 intradermal injections of anti-dinitrophenyl immunoglobulin E antibodies.

36 rotocol including measurement of HE-specific immunoglobulin E-antibodies in serum, skin prick tests,

37 The human immunoglobulin E antibody responses to the group 1 aller

38 e poor correlation between allergen-specific immunoglobulin E (asIgE) and clinical signs of allergy i

39 fector cells in allergic disorders and other immunoglobulin E-associated acquired immune responses th

40 on as effector and immunoregulatory cells in immunoglobulin E-associated allergic disorders, as well

41 -6, CXCL8), IL-12, CCL11, thromboxane B2 and immunoglobulin E at 24 h after local allergen challenge.

42 RI subunits for the formation of functional, immunoglobulin E-binding FcepsilonRI complexes during en

43 t cell-mediated hypersensitivity reaction to immunoglobulin E-bound allergens.

44 n-specific T-cell responses by internalizing immunoglobulin E-bound antigens for presentation to anti

45 Cross-linking of immunoglobulin E-bound FcepsilonRI triggers multiple cel

46 erin ectodomains fused to the Fc fragment of immunoglobulin (E-cad/Fc, N-cad/Fc, and P-cad/Fc) and im

47 measured the motion of fluorescently labeled immunoglobulin E complexed to high affinity receptors (F

48 llergen specificity, allergen-specific serum immunoglobulin E concentration, or individual laboratory

49 Allergen-specific serum immunoglobulin E concentrations ranged from 0.1 to 100 k

50 +)) influx; however, unlike that mediated by immunoglobulin-E crosslinking, it did not require the sp

51 49B1 is expressed on mast cells and inhibits immunoglobulin E-dependent activation and inflammation i

52 ved in the recruitment of neutrophils during immunoglobulin E-dependent gastric inflammation in the m

53 Immunoglobulin E-dependent gastric inflammation is chara

54 s can exacerbate ADHD symptoms and cause non-immunoglobulin E-dependent histamine release from circul

55 were increased in gastric tissues undergoing immunoglobulin E-dependent inflammation.

56 ond important action of ISS is inhibition of immunoglobulin E-dependent release of Th2 cytokines, esp

57 The high affinity receptor for immunoglobulin E (designated Fc epsilon RI) is the membe

58 Allergen-specific serum immunoglobulin E detection and quantification have becom

59 andard was carried out for allergen-specific immunoglobulin E determination using the fluoroimmunoenz

60 Allergen-specific serum immunoglobulin E determination with the fluoroimmunoenzy

61 kin tests and measurement of serum levels of immunoglobulin E do not accurately identify foods for el

62 In addition, immunoglobulin-E enhanced delta-toxin-induced mast cell

63 otal immunoglobulin E (TIgE), serum-specific immunoglobulin E, eosinophil count in peripheral blood,

64 osslinking of the high-affinity receptor for immunoglobulin E, F(c)epsilonRI.

65 ggregation of the high affinity receptor for immunoglobulin E (Fc epsilon RI) on mast cells results i

66 Aggregation of high-affinity receptors for immunoglobulin E (Fc epsilon RI) on the surface of mast

67 aling through the high affinity receptor for immunoglobulin E (Fc epsilon RI) results in the coordina

68 The high affinity receptor for immunoglobulin E (FcepsilonRI) in cultured mast (RBL-2H3

69 ss-linking of the high-affinity receptor for immunoglobulin E (FcepsilonRI) results in release of inf

70 ss-linking of the high-affinity receptor for immunoglobulin E (FcepsilonRI).

71 rough their receptors with high affinity for immunoglobulin E (FcepsilonRI).

72 n mediated by the high-affinity receptor for immunoglobulin E, FcepsilonRI, but the molecular basis i

73 he A-B loop of the Cepsilon3 domain of human immunoglobulin E has been carried out.

74 gation of the high-affinity Fc receptors for immunoglobulin E (IgE) (FcepsilonRI) on the surface of m

75 We measured specific Immunoglobulin E (IgE) against prevalent allergens and g

76 etecting human immunoglobulin G (IgG), human immunoglobulin E (IgE) and Aspergillus fumigatus antibod

77 ory-like', increased serum concentrations of immunoglobulin E (IgE) and caused dendritic cells to pro

78 d candidate genes for association with total immunoglobulin E (IgE) and effect modification by 25-hyd

79 Production of IL-4 and the generation of immunoglobulin E (IgE) and eosinophil responses were pre

80 -5 and IL-13, which induce the production of immunoglobulin E (IgE) and eosinophils [1,2].

81 cells express the high-affinity receptor for immunoglobulin E (IgE) and have been linked to host defe

82 mastocytosis and the production of both the immunoglobulin E (IgE) and IgG1 isotypes.

83 , this treatment increases parasite-specific immunoglobulin E (IgE) and other Th2 responses in the mo

84 s, characterized by increases in total serum immunoglobulin E (IgE) and specific serum IgG1 levels an

85 Immunoglobulin E (IgE) antibodies and mast cells have be

86 Immunoglobulin E (IgE) antibodies are known for triggeri

87 Immunoglobulin E (IgE) antibodies are pathogenic in asth

88 isdirected type 2 immune responses, in which immunoglobulin E (IgE) antibodies are produced against a

89 Immunoglobulin E (IgE) antibodies play a fundamental rol

90 In particular, the immunoglobulin E (IgE) antibody response to the carbohyd

91 The monoclonal anti-immunoglobulin E (IgE) antibody, omalizumab, was the fir

92 nsor, featuring a highly specific anti-human immunoglobulin E (IgE) aptamer as a capture probe, for h

93 isks) and to assess the oxaliplatin-specific immunoglobulin E (IgE) as a novel diagnostic tool.

94 he first to report high levels of functional immunoglobulin E (IgE) autoantibodies recognizing brain

95 To elucidate the immunoglobulin E (IgE) binding epitopes in the linear se

96 ne if D-amino acids (D-aas) bind and inhibit immunoglobulin E (IgE) binding to peanut allergens.

97 ), stably cross-links anti-2,4-dinitrophenyl-immunoglobulin E (IgE) bound to high affinity receptors

98 n: FM by plethysmography, total and specific immunoglobulin E (IgE) by automated immunosorbent analys

99 everal extracellular cues, including antigen-immunoglobulin E (IgE) complexes, bacteria, viruses, cyt

100 While serum immunoglobulin E (IgE) concentration has been shown to b

101 Framingham Heart Study data on total plasma immunoglobulin E (IgE) concentrations and found a number

102 nts stimulated by the mast cell receptor for immunoglobulin E (IgE) correlated with the affinity of a

103 Immunoglobulin E (IgE) exhibits a uniquely high affinity

104 Adoptive transfer of allergen-specific immunoglobulin E (IgE) from atopic donors to nonatopic r

105 Immunoglobulin E (IgE) has a major role in the pathogene

106 gths (I) on allergen extractability from and immunoglobulin E (IgE) immunoreactivity of peanut, almon

107 ctivated B lymphocyte increases the level of immunoglobulin E (IgE) in a protein kinase A (PKA)- and

108 Despite the critical role of immunoglobulin E (IgE) in allergy, circulating IgE+ B ce

109 n of low concentrations of allergen-specific Immunoglobulin E (IgE) in human sera using a Photonic Cr

110 itative immunoassay for the determination of immunoglobulin E (IgE) in human serum using gold nanoclu

111 activation of the high-affinity receptor for immunoglobulin E (IgE) in mast cells.

112 high-affinity Fc receptor (FcepsilonRI) for immunoglobulin E (IgE) in MC/9 mouse mast cells stimulat

113 Capture and detection of immunoglobulin E (IgE) in simple solution and in human s

114 lper (Th) 2 cells, the physiological role of immunoglobulin E (IgE) in the airway remains largely und

115 Immunoglobulin E (IgE) is a central mediator of allergic

116 Serum total immunoglobulin E (IgE) is a critical intermediate phenot

117 Immunoglobulin E (IgE) is believed to be one of the majo

118 The authors investigated if cord blood immunoglobulin E (IgE) is dependent upon birth order and

119 r-based biosensor for the detection of human immunoglobulin E (IgE) is developed using the electroche

120 Immunoglobulin E (IgE) is important in mediating human a

121 Immunoglobulin E (IgE) is pathogenic in allergic disease

122 mucosal tissues of allergic reactions, where immunoglobulin E (IgE) is produced locally.

123 Immunoglobulin E (IgE) is well known for its role in all

124 B cells expressing antibodies of the immunoglobulin E (IgE) isotype are rare, yet are heavily

125 antibody levels revealed an increase in the immunoglobulin E (IgE) level in immunized mice.

126 and no significant elevation in the systemic immunoglobulin E (IgE) level.

127 Elevated serum Immunoglobulin E (IgE) levels and increased airway respo

128 study examined the association between serum immunoglobulin E (IgE) levels for a panel of common indo

129 rhinitis, and itchy rash) and serum-specific immunoglobulin E (IgE) levels from the 2005-2006 Nationa

130 Comparison of OVA-specific immunoglobulin E (IgE) levels in the serum and numbers o

131 Total serum immunoglobulin E (IgE) levels were significantly lower i

132 ry, maternal and paternal total and specific Immunoglobulin E (IgE) levels, and cord blood IgE were r

133 erresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests positive t

134 ed based on increased IL-5 production, total immunoglobulin E (IgE) levels, antigen-specific IgG1 res

135 f intermediate phenotypes, one each on serum immunoglobulin E (IgE) levels, blood eosinophil counts a

136 Total serum immunoglobulin E (IgE) levels, for example, show strong

137 Canonically, immunoglobulin E (IgE) mediates allergic immune response

138 Immunoglobulin E (IgE) mediates its effector functions v

139 Immunoglobulin E (IgE) mediates many of the inflammatory

140 estigated how the high-affinity receptor for immunoglobulin E (IgE) modulates the response of mast ce

141 ceptor for the Fc region of antigen-specific immunoglobulin E (IgE) molecules.

142 acebo-controlled clinical trials of the anti-immunoglobulin E (IgE) monoclonal antibody, rhuMAb-E25 (

143 e current study, we used omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, to demonstra

144 basophils that express a particular type of immunoglobulin E (IgE) or IgE+, was found to induce inte

145 ividuals is that parasite-induced polyclonal immunoglobulin E (IgE) out-competes allergen-specific Ig

146 omosome 14q was screened for loci modulating immunoglobulin E (IgE) phenotypes in 15 extended and 45

147 cell type 2 (Th2) responses leading to hyper-immunoglobulin E (IgE) production and allergy.

148 as suggested an increase in antigen-specific immunoglobulin E (IgE) production during viral infection

149 draining lymph node (DLN) cell infiltrates, immunoglobulin E (IgE) production, and airway hyper-resp

150 igated the relationship between the specific immunoglobulin E (IgE) profile for 40 allergens using a

151 This study analysed Immunoglobulin E (IgE) profiles to single allergen compo

152 Cross-linkage of the high-affinity immunoglobulin E (IgE) receptor (FcvarepsilonRI) on mast

153 tiated by cross-linking of the high-affinity immunoglobulin E (IgE) receptor FcepsilonRI.

154 The low-affinity immunoglobulin E (IgE) receptor, CD23 (FcepsilonRII), bi

155 and basophils that express the high-affinity immunoglobulin E (IgE) receptor, Fc epsilon receptor 1 (

156 ates upon cross-linking of the high-affinity immunoglobulin E (IgE) receptor.

157 ROSA(KIT WT), expressing a fully functional immunoglobulin E (IgE) receptor.

158 Specific immunoglobulin E (IgE) responses are upregulated during

159 by which allergic patients develop specific immunoglobulin E (IgE) responses to environmental allerg

160 he basis of immune deviation that results in immunoglobulin E (IgE) sensitization and allergic reacti

161 ociated with concomitant atopic diseases and immunoglobulin E (IgE) sensitization to food allergens i

162 gher baseline levels of schistosome-specific immunoglobulin E (IgE) than did children with > or =2 re

163 The binding of immunoglobulin E (IgE) to high affinity IgE receptors (F

164 s in the allergic reaction is the binding of immunoglobulin E (IgE) to its high affinity receptor (Fc

165 s is reported for the sensitive detection of immunoglobulin E (IgE) using fluorescence polarization (

166 isease and asthma, and more than 30 yr since immunoglobulin E (IgE) was identified as the key molecul

167 nce and binding properties of an aptamer for immunoglobulin E (IgE) was investigated using custom DNA

168 ns at the site of infection and infection of immunoglobulin E (IgE)(-/-) mice, lead us to suggest tha

169 gnificant reduction in STH prevalence, total immunoglobulin E (IgE), and eosinophil count.

170 CD4-CD8- peripheral T cells, elevated serum immunoglobulin E (IgE), and possible pulmonary inflammat

171 markers of Th2 inflammation, reducing serum immunoglobulin E (IgE), chemokine ligands 13 and 17 by a

172 r, the level of a systemic Th2 marker, serum immunoglobulin E (IgE), correlated significantly with SR

173 cells by phosphorylation of the receptor for immunoglobulin E (IgE), FcepsilonRI, by Lyn kinase after

174 g by antigen, the high affinity receptor for immunoglobulin E (IgE), FcepsilonRI, is phosphorylated b

175 y fever, allergic sensitization, serum total immunoglobulin E (IgE), forced expiratory volume in one-

176 of allergens, and geometric mean serum total immunoglobulin E (IgE), in 3451 participants aged 18-75

177 We know now that this factor is immunoglobulin E (IgE), sensitizing mast cells and basop

178 The distinguishing structural feature of immunoglobulin E (IgE), the antibody responsible for all

179 We identified unique signatures for AD (Immunoglobulin E (IgE), thymus- and activation-regulated

180 Their activation via immunoglobulin E (IgE)-antigen interactions is promoted

181 f LPA were functional, as evidenced by their immunoglobulin E (IgE)-dependent histamine release and b

182 The structure of immunoglobulin E (IgE)-Fc(3-4) has been solved in three

183 an emphasis on novel FcepsilonRI regulators, immunoglobulin E (IgE)-independent pathways [e.g., Mas-r

184 during pregnancy may reduce the incidence of immunoglobulin E (IgE)-mediated allergic disease.

185 Atopic or immunoglobulin E (IgE)-mediated diseases include the com

186 ldhood asthma are associated with atopy, the immunoglobulin E (IgE)-mediated familial syndrome of all

187 Atopy is characterized by immediate immunoglobulin E (IgE)-mediated hypersensitivity to agen

188 psilonRI beta chain, a molecule important in immunoglobulin E (IgE)-mediated immunity.

189 a consequence of antigen-aggregation of the immunoglobulin E (IgE)-occupied high affinity receptor f

190 Immunoglobulin E (IgE)-sensitization to peanut is common

191 y allergen in complex with allergen-specific immunoglobulin E (IgE).

192 erized by substantial increases in levels of immunoglobulin E (IgE).

193 immunoglobulin class switch-recombination to immunoglobulin E (IgE).

194 ndent on the acquisition of antigen-specific immunoglobulin E (IgE).

195 sthma, atopic dermatitis, and elevated total immunoglobulin E (IgE).

196 nsitivity (DTH) to SEA; high levels of serum immunoglobulin E (IgE); a strong T2 cytokine phenotype w

197 ation through the high-affinity receptor for immunoglobulin E (IgE; FcepsilonRI).

198 The initiation of immunoglobulin-E (IgE)-mediated allergic responses requi

199 tood, the disease is mediated by an abnormal immunoglobulin-E immune response in the setting of skin

200 Cat- and cockroach-sensitive (immunoglobulin E immunocap [Cap] class > or = 1) women w

201 complete lack of prevailing Sm-p80-specific immunoglobulin E in a high-risk or infected population w

202 maternal parasitemia and levels of PLAP and immunoglobulin E in cord blood.

203 gen-specific serum immunoglobulins and total immunoglobulin E in different groups of animals were mea

204 ecurrent respiratory infections and elevated immunoglobulin E in serum.

205 sis in the jejunum and had reduced ovalbumin-immunoglobulin E in their serum, compared with TSLPR(+/+

206 These studies highlight a mast cell- and immunoglobulin E-independent role for CCR6-bearing T cel

207 essential role in antigen sensitization and immunoglobulin E induction, stimulate dendritic cell acc

208 Also, substantial reductions in plasma total immunoglobulin E, interleukin (IL)-1beta, and tumor necr

209 nificantly correlated with decrease in total immunoglobulin E level (rho = 0.47; P = .04).

210 can data set and incorporate the total serum immunoglobulin E level in the analysis.

211 rd the T helper 2 type, with increased total immunoglobulin E levels (P<.06) and a tendency toward in

212 OVA-specific Th1 to Th2 cells and decreased immunoglobulin E levels after allergen challenge as adul

213 antigen treatments resulted in reduced total immunoglobulin E levels and peripheral blood eosinophil

214 g doxorubicin and trastuzumab, high baseline immunoglobulin E levels are associated with a lower risk

215 tions between multiple VDR polymorphisms and immunoglobulin E levels were also observed (p = 0.006-0.

216 l alkaline phosphatase (PLAP) and polyclonal immunoglobulin E levels were also quantified in paired m

217 h doxorubicin and trastuzumab, high baseline immunoglobulin E levels were associated with a significa

218 Serum immunoglobulin E levels were increased in IL-13Ralpha2-/

219 4 production by NKT cells, to increase serum immunoglobulin E levels, and to promote the generation o

220 urrent viral and bacterial infections, hyper-immunoglobulin E levels, eczema, and greater susceptibil

221 allenge with ovalbumin, as measured by total immunoglobulin E levels, ovalbumin-specific immunoglobul

222 ine production, eosinophil influx, and serum immunoglobulin E levels.

223 iotemporal dynamics of the redistribution of immunoglobulin E-loaded receptors (IgE-FcepsilonRI) on r

224 etion of cytokines involved in regulation of immunoglobulin E, mast cells, basophils and eosinophils,

225 lower immunoglobulin A (median, 1:3,200) and immunoglobulin E (median, 1:128) titers to rAls3p-N by e

226 ceptor (FcepsilonRI) complex is dedicated to immunoglobulin E-mediated allergic responses.

227 ted with traits underlying asthma and atopy (immunoglobulin E-mediated allergy).

228 d mouse mast cells inhibited antigen-induced immunoglobulin E-mediated cell activation.

229 tive incidence to be 0.34% by 1 year of age; immunoglobulin E-mediated cow's milk allergy was 0.5%.

230 f the information available still relates to immunoglobulin E-mediated food reactions, although other

231 Rgs13-/- mice had enhanced immunoglobulin E-mediated mast cell degranulation and an

232 Mast cells contribute to immunoglobulin-E-mediated allergic disorders including a

233 rvoir after antigen capture through specific immunoglobulin E molecules bound to their FcepsilonRI.

234 Omalizumab, an anti-immunoglobulin E monoclonal antibody, has transformed th

235 FcepsilonRI, the high-affinity receptor for immunoglobulin E, on RBL-2H3 mast cells results in its c

236 was not apparent following plate-bound anti-immunoglobulin E or SEA stimulation.

237 Allergen-specific immunoglobulin E (present in allergic sensitization) has

238 y enhanced type 2 responses (IL-4, IL-5, and immunoglobulin E production) upon in vitro TCR stimulati

239 mal allergen-induced airway hyperreactivity, immunoglobulin E production, mucus metaplasia, and airwa

240 reduced T2 cytokine production and no serum immunoglobulin E production.

241 Furthermore, enhancement of immunoglobulin-E production and dermatitis by delta-toxi

242 sera from soybean-sensitive individuals have immunoglobulin E reactivity to abundant storage proteins

243 d performed serological analyses of specific immunoglobulin E reactivity.

244 these cells, cross-linking the high-affinity immunoglobulin E receptor (FcepsilonR1) leads to activat

245 The high affinity immunoglobulin E receptor (FcepsilonRI) complex is dedic

246 mediators after antigen crosslinking of the immunoglobulin E receptor FcepsilonRI.

247 on when RBL-2H3 cells are stimulated via the immunoglobulin E receptor, Fc epsilon RI.

248 CD23, the low-affinity immunoglobulin E receptor, is an important modulator of

249 lso showed functional defects; high-affinity immunoglobulin E receptor-mediated degranulation was sig

250 tive [Lin-]/CD34hi/CD117int/hi/high-affinity immunoglobulin E receptor-positive [FcepsilonRI+]), with

251 stematic effort to determine the features of immunoglobulin E-receptor (IgE-Fc epsilon RI) aggregatio

252 We find that antigen stimulation of immunoglobulin E receptors causes much less Orai1/CRACM1

253 (IL)-4 and IL-5 and posttreatment levels of immunoglobulin E recognizing the parasite's tegument (Te

254 Robert L. Coffman recounts how his work on immunoglobulin E regulation along with data from Tim Mos

255 duce iBALTs, which coincided with subsequent immunoglobulin E responses, and IL-1-receptor-deficient

256 Immunoglobulin E sensitization was almost exclusively di

257 d treatments of asthma, rhinitis and eczema; immunoglobulin E sensitization; weight; and height.

258 disease, which is frequently associated with immunoglobulin-E sensitization to ubiquitous fungi, typi

259 ences in the number of sensitizations, total immunoglobulin E serum levels and predilection of the sk

260 termined by skin prick tests (SPT); specific immunoglobulin E (sIgE) titers against 12 common allerge

261 to analyze the diagnostic value of specific immunoglobulin E (sIgE) to Gly m 2S albumin, Gly m 4, 5,

262 e, history, skin prick test, peanut specific immunoglobulin E (sIgE), and total IgE minus peanut sIgE

263 s leads to diseases such as cancer and hyper-immunoglobulin E syndrome (HIES).

264 efit from targeted anti-interleukin and anti-immunoglobulin E therapies, and in monitoring subsequent

265 ts for seasonal allergic rhinitis, and alpha-immunoglobulin E therapy for asthma.

266 om inhaled corticosteroids and targeted anti-immunoglobulin E therapy.

267 hacholine (MTCH)-challenge test, serum total immunoglobulin E (TIgE), serum-specific immunoglobulin E

268 immunoglobulin E levels, ovalbumin-specific immunoglobulin E titers, and eosinophil content of bronc

269 sing allergic lung inflammation and elevated immunoglobulin E titers.

270 Specific immunoglobulin E to Gly m 2S albumin had the best accura

271 Specific immunoglobulin E to Gly m 2S albumin had the highest AUC

272 re added, with oral corticosteroids and anti-immunoglobulin E treatment with omalizumab for the most

273 Immunoglobulin E-triggered anaphylactic responses, inclu

274 in serum antigen-specific immunoglobulin G1/immunoglobulin E using ovalbumin or Aspergillus fumigatu

275 d gel-phase membranes displaying ligands for immunoglobulin E, using total internal reflection fluore

276 Immunoglobulin E was lower in children with measles, des

277 umulation of eosinophils and levels of serum immunoglobulin E were increased in NFAT1 -/- mice.

278 kers of oxidative stress, thromboxane B2 and immunoglobulin E were measured in bronchoalveolar lavage

279 alloproteinase-9 total, apolipoprotein E and immunoglobulin E--were used along with co-variates in mu

280 t differences between cases and controls was immunoglobulin E, with higher levels detected at baselin